Lataa...
Chondroblastoma: Is intralesional curettage with the use of adjuvants a sufficient way of therapy?
BACKGROUND: Chondroblastoma is a rare benign cartilaginous bone tumor that represents 1–2% of all primary bone tumors. It is characterized by aggressive growth, possible recurrence after surgical treatment and, in rare cases, metastasis. Surgical management is the primary treatment and includes intr...
Tallennettuna:
| Julkaisussa: | J Bone Oncol |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7750402/ https://ncbi.nlm.nih.gov/pubmed/33364155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2020.100342 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|